ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Philip Morris International acquires OtiTopic expresspharma
August 11, 2021This acquisition is part of PMI's strategic plan to leverage its expertise, scientific know-how and capabilities in inhalation to grow a pipeline of inhaled therapeutics and respiratory drug delivery Beyond Nicotine. -
Philip Morris Heats Up Race for Vectura With $1.4 Billion Bid firstwordpharma
August 09, 2021Philip Morris International on Sunday bid ￡1.65 per share for Vectura Group, after Carlyle on Friday offered ￡1.50 per share, Bloomberg reported. -
Philip Morris agrees to acquire Vectura for $1.45bn pharmaceutical-technology
July 13, 2021Philip Morris International (PMI) has made an offer to acquire a contract development and manufacturing organisation (CDMO), Vectura Group, for approximately $1.45bn (￡1.045bn) to boost its product pipeline development expertise in inhaled treatments.
Pharma Sources Insight January 2025
